SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Nov. 10, 2005--FibroGen, Inc., today announced the appointment of Russell H. Ellison as Vice President of Clinical Development. Dr. Ellison brings over 26 years of pharmaceutical industry experience in the leadership of clinical development, medical and regulatory affairs, and drug safety functions. At FibroGen, Dr. Ellison will focus on expansion of the Company’s clinical development team and rapid advancement of key clinical programs in anemia, diabetic nephropathy, and dermal augmentation through approval and commercialization.
